UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 8
August-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2308491


Registration ID:
523666

Page Number

e785-e787

Share This Article


Jetir RMS

Title

CARBETOCIN A PROMISING ADVANCEMENT IN THE MANAGEMENT OF POSTPARTUM HEMORRHAGE

Abstract

Postpartum haemorrhage (PPH) is a major global problem that affects maternal morbidity and mortality. Carbetocin, a synthetic oxytocin analogue, has been found to be a possible new therapeutic option for PPH in recent studies. Carbetocin has various advantages over standard therapy, including a longer half-life, higher stability, and improved uterotonic action. These characteristics make it an appealing alternative to oxytocin, the standard uterotonic medication used in PPH therapy. The prolonged duration of action of carbetocin can lower the likelihood of recurrent bleeding and the need for further therapies, resulting in better maternal outcomes. Carbetocin has been found to reduce blood loss and the need for extra uterotonics during postpartum haemorrhage care. When carbetocin was compared against oxytocin in a major multicentre study, it was shown to be non-inferior in terms of blood loss and uterine atony. Because of its superior uterotonic characteristics, carbetocin is especially beneficial in instances of PPH caused by uterine atony. It has a better safety profile than oxytocin, with no substantial increase in adverse events. Additional study is required to investigate appropriate doses, delivery methods, and cost-effectiveness. Carbetocin is expected to become the recommended therapy for postpartum haemorrhage as more research and clinical experience accumulate.

Key Words

CARBETOCIN, postpartum haemorrhage care

Cite This Article

"CARBETOCIN A PROMISING ADVANCEMENT IN THE MANAGEMENT OF POSTPARTUM HEMORRHAGE ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.e785-e787, August-2023, Available :http://www.jetir.org/papers/JETIR2308491.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"CARBETOCIN A PROMISING ADVANCEMENT IN THE MANAGEMENT OF POSTPARTUM HEMORRHAGE ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. ppe785-e787, August-2023, Available at : http://www.jetir.org/papers/JETIR2308491.pdf

Publication Details

Published Paper ID: JETIR2308491
Registration ID: 523666
Published In: Volume 10 | Issue 8 | Year August-2023
DOI (Digital Object Identifier):
Page No: e785-e787
Country: HULIMAVU , KARNATAKA , India .
Area: Biological Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000116

Print This Page

Current Call For Paper

Jetir RMS